Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2007-12-11FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Tegretol (carbamazepine) filed by Novartis Pharmaceuticals Corporation.
-
FDA label_change · 2007-12-11FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Tegretol (carbamazepine) filed by Novartis Pharmaceuticals Corporation. The update concerns …
-
FDA approval · 2007-12-11FDA Approved: OXCARBAZEPINE — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' original application for oxcarbazepine, a generic anticonvulsant indicated for partial-onset seizures …
-
CLINICAL_TRIALS trial_result · 2007-11-30Clinical Trial Update: Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures [Phase 4]
Phase 4 trial results evaluate the safety and efficacy of oxcarbazepine as monotherapy in adults with partial seizures.
-
CLINICAL_TRIALS trial_result · 2007-11-29Clinical Trial Update: RCT of the Efficacy of the Ketogenic Diet in the Treatment of Epilepsy [Phase 4]
A Phase 4 randomized trial evaluating the efficacy of the ketogenic diet for treating epilepsy has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2007-10-31Clinical Trial Update: Hormone Profiles in Adults With Newly Diagnosed Epilepsy [Phase 4]
A Phase 4 clinical trial conducted by the Chinese University of Hong Kong is investigating hormone profiles in adults with newly diagnosed e…
-
FDA approval · 2007-10-29FDA Approved: LORAZEPAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Lorazepam from Hikma Pharmaceuticals USA Inc., authorizing the marketing of a Lorazepam product.
-
CLINICAL_TRIALS research · 2007-10-12Clinical Trial Update: PET Study of the Nicotinic Receptors in Human
This clinical trial evaluating nicotinic receptor PET imaging in humans was terminated; it enrolled healthy individuals and patients with Pa…
-
FDA approval · 2007-10-09FDA Approved: OXCARBAZEPINE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' original application for a generic oxcarbazepine product. This marks approval of a generic versi…
-
FDA approval · 2007-10-09FDA Approved: OXCARBAZEPINE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved the original ANDA for oxcarbazepine from Glenmark Pharmaceuticals.
-
FDA approval · 2007-09-12FDA Approved: KEPPRA — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for Keppra (levetiracetam) submitted by UCB, Inc., resulting in updated labeling/indication as part …
-
FDA approval · 2007-09-12FDA Approved: KEPPRA — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for Keppra (levetiracetam) from UCB, Inc., expanding the product's approved use and/or labeling.
-
FDA approval · 2007-09-12FDA Approved: ZONISAMIDE — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for zonisamide submitted by BluePoint Laboratories. The approval indicates authorization for cha…
-
FDA approval · 2007-08-31FDA Approved: TRILEPTAL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for TRILEPTAL (oxcarbazepine) from Novartis Pharmaceuticals Corporation. The action updates labe…
-
FDA approval · 2007-08-31FDA Approved: TRILEPTAL — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for TRILEPTAL (oxcarbazepine) from Novartis, resulting in a label update for the product.
-
FDA approval · 2007-08-16FDA Approved: TEGRETOL XR — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Tegretol XR (carbamazepine) submitted by Novartis Pharmaceuticals Corporation.
-
FDA approval · 2007-08-16FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Tegretol (carbamazepine) filed by Novartis Pharmaceuticals Corporation; the approval updates the…
-
FDA approval · 2007-08-08FDA Approved: DILANTIN — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Dilantin (extended phenytoin sodium) filed by Viatris Specialty LLC.
-
FDA approval · 2007-08-06FDA Approved: FOSPHENYTOIN — Original Application (Fresenius Kabi USA, LLC)
FDA approved the original ANDA for fosphenytoin sodium (FOSPHENYTOIN) by Fresenius Kabi USA, LLC.
-
FDA approval · 2007-08-06FDA Approved: FOSPHENYTOIN SODIUM — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved the original ANDA for fosphenytoin sodium, a generic version of the anticonvulsant, manufactured by Hikma Pharmaceuticals USA I…
-
CLINICAL_TRIALS trial_result · 2007-07-23Clinical Trial Update: Study of Antiepileptic Drug Effects on Child Development
This update notes the completion of a clinical trial evaluating the effects of antiepileptic drugs on child development in individuals with …
-
FDA approval · 2007-06-21FDA Approved: LYRICA — Supplemental Application (Parke-Davis Div of Pfizer Inc)
The FDA approved a supplemental application for LYRICA (pregabalin) submitted by Parke-Davis (Pfizer) to update the labeling with expanded o…
-
CLINICAL_TRIALS research · 2007-05-01Clinical Trial Update: Role of Antibodies Against Glutamate Receptors and Double Stranded DNA in Epilepsy Patients
A clinical trial update examining the role of antibodies against glutamate receptors and double-stranded DNA in epilepsy patients. The study…
-
CLINICAL_TRIALS trial_result · 2007-04-19Clinical Trial Update: Pediatric Epilepsy Database
The clinical trial 'Pediatric Epilepsy Database' sponsored by the University of Alabama at Birmingham has completed. The study focused on ep…
-
CLINICAL_TRIALS trial_result · 2007-03-23Clinical Trial Update: Observational Study of Lamotrigine
This document reports the completion of an observational study of lamotrigine in epilepsy.